Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Cameron DA, White JM, Proctor SJ, Prescott RJ, Leonard RC, Angus B, Cook MK, Dawes PJ, Dawson AA, Evans RG, Galloway MJ, Harris AL, Heppleston A, Horne CH, Krajewski AS, Lennard AL, Lessells AM, Lucraft HH, MacGillivray JB, Mackie MJ, Parker AC, Roberts JT, Taylor PR, Thompson WD. Cameron DA, et al. Among authors: lennard al. Eur J Cancer. 1997 Jul;33(8):1195-201. doi: 10.1016/s0959-8049(97)00051-8. Eur J Cancer. 1997. PMID: 9301442 Clinical Trial.
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK.
Jackson GH, Wood A, Taylor PR, Lennard AL, Lucraft H, Heppleston A, Robinson P, Moore J, Proctor SJ. Jackson GH, et al. Among authors: lennard al. Leuk Lymphoma. 1997 Dec;28(1-2):127-32. doi: 10.3109/10428199709058338. Leuk Lymphoma. 1997. PMID: 9498711
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Jackson GH, Angus B, Carey PJ, Finney RD, Galloway MJ, Goff DK, Haynes A, Lennard AL, Leonard RC, McQuaker IG, Proctor SJ, Russell N, Windebank K, Taylor PR; Scotland and Newcastle Lymphoma Group. Jackson GH, et al. Among authors: lennard al. Leuk Lymphoma. 2000 May;37(5-6):561-70. doi: 10.3109/10428190009058508. Leuk Lymphoma. 2000. PMID: 11042516 Clinical Trial.
71 results